Bavencio

Roche fails in bladder cancer

Just weeks after Merck's checkpoint inhibitor Keytruda secured FDA approval for a subset of patients with bladder cancer, it has...

Immunicum's ilixadencel gives new hope to cancer patients

With three ongoing clinical studies, reports await...

Keytruda takes leadership position in kidney cancer

In 2019, there will be around 73,820 new cases of...

Bill Gates sees great potential in personalized cancer treatment

The prestigious journal MIT Technology Review has eighteen years...

Study results from immunotherapy combo against kidney cancer speak in favor of Immunicum

Recently published